Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 72603-399

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 72603-399). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Mpd Er 72 mg Figure 1)

This text provides information on the mean plasma concentration of Methylphenidate for Extended-Release Tablets at a dose of 18 mg once daily and for regular Methylphenidate tablets at a dose of 5 mg three times daily.*

FDA Label Image

Fig2 (Mpd Er 72 mg Figure 2)

This is a comparison of symptoms reported between individuals taking Methylphenidate Hydrochloride Extended-Release tablets once daily and those taking a placebo. The study involves three different studies (Study1, Study2, and Study3) at Week 4, with a total of 61 participants in each group. The results show a decrease in symptoms in the group taking Methylphenidate Hydrochloride compared to the placebo group.*

FDA Label Image

Fig3 (Mpd Er 72 mg Figure 3)

This is not readable.*

FDA Label Image

Structure (Methylphenidate 01)

FDA Label Image

Mpd-er-72mg (Methylphenidate Spl Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.